Module 3 Quiz Pharm

Module 3 Quiz pharm A young female patient is seen in a rural clinic after complaining of abdominal pain. The patient is wearing dirty clothing and is barefoot. The provider orders a complete blood count, which shows that the patient is anemic. The nurse may suspect that this patient has which of the following infestations? a. Ancylostomiasis (hookworm) b. Trichuriasis (whipworm) c. Ascariasis (giant roundworm) d. Enterobiasis (pinworm) A nurse is preparing to administer medications to a patient who has recently started on delavirdine [Rescriptor]. Which concurrent prescription should the nurse question before administration? a. Diphenhydramine [Benadryl] b. Penicillin c. Morphine d. Alprazolam [Xanax] A patient is taking diethylcarbamazine [Hetrazan] to treat a filarial infestation. The patient reports intense itching and a rash after several days of therapy. What will the nurse tell this patient? a. This warrants discontinuation of the drug. b. This is a minor, direct adverse effect of the drug. c. This is a sign the infestation is worsening. d. These symptoms are caused by death of the parasite. A female patient who has hepatitis C is being treated with pegylated interferon alfa and ribavirin [Ribasphere]. It will be important for the nurse to teach this patient that: a. she should use a hormonal contraceptive to avoid pregnancy. b. she will need a monthly pregnancy test during her treatment. c. if she gets pregnant, she should use the inhaled form of ribavirin [Virazole]. d. if she is taking oral contraceptives, she should also take a protease inhibitor. A patient with high-risk factors for tuberculosis will begin therapy for latent TB with isoniazid and rifampin. The nurse learns that this patient takes oral contraceptives. The nurse will counsel this patient to discuss ____ with her provider. a. reducing the rifampin dose b. another birth control method c. reducing the isoniazid dose d. increasing the oral contraceptive dose A patient is taking oral ketoconazole [Nizoral] for a systemic fungal infection. The nurse reviews the medication administration record and notes that the patient is also taking omeprazole [Prilosec] for reflux disease. Which action should the nurse take? a. The nurse should not administer the omeprazole to a patient receiving ketoconazole. b. Administer the omeprazole at least 2 hours after the ketoconazole. c. Confer with the prescriber about a potential hazardous interaction. d. Administer the omeprazole 1 hour before the ketoconazole. A child has been diagnosed with enterobiasis, and the prescriber orders mebendazole [Vermox] to treat the infestation. When teaching this child’s parents about the treatment, the nurse will include which statement? a. “Treatment should be limited to family members with symptoms.” b. “A single dose of mebendazole will eradicate the infestation.” c. “Serious complications of this type of infestation are common.” d. “Everyone in the household should be treated with mebendazole.” A nursing student asks a nurse why tuberculosis resistance is so high. Which reasons are correct? (Select all that apply.) a. Many hosts are immunocompromised. b. Adherence to drug regimens is erratic. c. Some TB drugs are bacteriostatic. d. Many regimens contain too few drugs. e. Drug doses are often too low. A patient starting therapy with efavirenz [Sustiva] asks about the timing of the medication with regard to meals. Which patient education about the administration of this medication should the nurse provide? a. The drug can be taken anytime without regard to meals. b. The drug is best taken with a high-fat meal. c. The drug should be taken once daily on an empty stomach. d. The drug must be taken within 30 minutes after a meal. A male patient with hepatitis C will begin triple drug therapy with pegylated interferon alfa 2a [Pegasys], ribavirin [Ribasphere], and boceprevir [Victrelis]. The patient tells the nurse that his wife is pregnant. What will the nurse tell him? a. Boceprevir is contraindicated in males whose partners are pregnant. b. He should use dual drug therapy with pegylated interferon alfa and ribavirin only. c. He should use a barrier contraceptive when having sex. d. This combination drug therapy is safe for him to use. A patient is being treated with amphotericin B [Abelcet] for a systemic fungal infection. After several weeks of therapy, the provider orders flucytosine [Ancobon] in addition to the amphotericin. The nurse understands that the rationale for this combination is that it: a. broadens the antifungal spectrum. b. lowers the dose of amphotericin B and reduces toxicity. c. improves the effectiveness of the amphotericin B. d. treats fungal central nervous system (CNS) infection. A patient who has contracted falciparum malaria has received a prescription for artemether/lumefantrine [Coartem] and tells the nurse she thinks she may be pregnant. What will the nurse tell this patient? a. “Ask your provider about taking only the artemether component.” b. “You should talk to your provider about a different medication.” c. “The medication should be taken with food to prevent nausea.” d. “This drug is safe during the first trimester of pregnancy.” A patient is being treated for a systemic fungal infection with amphotericin B [Abelcet] and will be discharged home from the hospital to complete every other day infusions of the medication for 6 to 8 weeks. The nurse provides discharge teaching before dismissal. Which statement by the patient indicates a need for further teaching? a. “I may need to take potassium supplements while taking this drug.” b. “I should take acetaminophen and diphenhydramine before each infusion.” c. “I may experience headaches and pain in my lower back, legs, and abdomen.” d. “I will need to have blood drawn for serum creatinine and BUN levels every 3 to 4 days.” A patient with HIV contracts herpes simplex virus (HSV), and the prescriber orders acyclovir [Zovirax] 400 mg PO twice daily for 10 days. After 7 days of therapy, the patient reports having an increased number of lesions. The nurse will expect the provider to: a. give intravenous foscarnet every 8 hours for 2 to 3 weeks. b. extend this patient’s drug therapy to twice daily for 12 months. c. increase the acyclovir dose to 800 mg PO 5 times daily. d. order intravenous valacyclovir [Valtrex] 1 gm PO twice daily for 10 days. patient is about to begin treatment for latent tuberculosis with a short course of daily rifampin. The patient asks why rifapentine [Priftin] cannot be used, because it can be given twice weekly. What will the nurse tell this patient about rifapentine? a. It is not approved for treatment of latent TB. b. It is not well absorbed and thus not as effective. c. It will stain contact lenses orange. d. It is more toxic than rifampin. Which patient shouldnot use lindane?(Select all that apply.) a. A person with an autoimmune disorder b. A patient who has used lindane in the past 2 months c. A person with atopic dermatitis d. A person who weighs 115 pounds e. A child with a history of seizures A patient comes to the clinic and receives valacyclovir [Valtrex] for a herpes-zoster virus. The nurse instructs the patient to take the medication: a. without regard to meals. b. each morning. c. on an empty stomach. d. without any dairy products. A patient will begin treatment with posaconazole [Noxafil] to treat oropharyngeal candidiasis that has not responded to fluconazole. The provider has ordered 200 mg 3 times daily. Which action by the nurse is correct? a. Suggest to the provider that this dose may be too high for this indication. b. Administer the drug as ordered. c. Discuss a 400-mg twice daily drug regimen with the provider. d. Contact the provider to discuss decreasing the dose to twice daily. A nurse is teaching a group of nursing students about influenza prevention. Which statement by a student indicates understanding of the teaching? a. “I should receive the vaccine every year in October or November.” b. “The antiviral medications are as effective as the flu vaccine for preventing the flu.” c. “I may develop a mild case of influenza if I receive the vaccine by injection.” d. “If I have a cold I should postpone getting the vaccine.” Which antibiotics may be administered topically? (Select all that apply.) a. Bacitracin b. Daptomycin c. Ofloxacin d. Polymyxin B e. Rifampin A patient who is taking ketoconazole tells the nurse that her periods have become irregular. What will the nurse tell her? a. This is caused by a reversible effect on estradiol synthesis. b. This is a serious side effect that warrants discontinuation of the drug. c. This indicates that she should begin taking oral contraceptives. d. This is a sign of hepatic toxicity, and the drug dose should be lowered. Two days after a child is treated with permethrin [Elimite] for head lice, a parent calls the clinic to report seeing nits and a few live lice on the child’s scalp. The nurse will tell the parent to: a. Use a fine-toothed comb to remove nits and live lice. b. Ask the provider about using benzyl alcohol [Ulesfia]. c. Cut the areas of the child’s hair where nits are present. d. Retreat the child’s hair with permethrin [Elimite]. A nurse is caring for a patient who is receiving amphotericin B [Abelcet] for a systemic fungal infection. In spite of receiving diphenhydramine and acetaminophen before initiation of treatment, the patient has fever and chills with rigors. The nurse will contact the provider to discuss the addition of which drug? a. Aspirin b. Hydrocortisone c. Dantrolene d. Omeprazole A patient who is being treated for HIV infection has a 5-mm area of induration after a routine TST. The patient’s chest radiograph is normal, and there are no other physical findings. The nurse will expect this patient to begin treatment with which drugs? a. Isoniazid and pyrazinamide b. Isoniazid and rifampin c. Isoniazid and rifapentine d. Isoniazid and rifabutin A patient is beginning treatment for active tuberculosis (TB) in a region with little drug-resistant TB. Which treatment regimen will be used initially? a. Isoniazid, pyrazinamide, and ethambutol b. Isoniazid and pyrazinamide c. Rifampin, pyrazinamide, and ethambutol d. Isoniazid, rifampin, pyrazinamide, and ethambutol